B-Cells and Plasmablasts as Architects of Autoimmune Disease: From Molecular Footprints to Precision Therapeutics
Cells · 09.01.2026 · 15 (2) · 119
DOI: 10.3390/cells15020119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 09.01.2026. Verfasst von Julie Sarrand und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium. Hauptthemen laut MEDLINE: Autoimmune Diseases, B-Lymphocytes, Plasma Cells, Precision Medicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
B-cells and plasmablasts have emerged as central organizers of autoimmune pathogenesis, extending far beyond their classical role as antibody-producing cells to orchestrate immune circuits, tissue microenvironments, and therapeutic trajectories. Advances in single-cell technologies, high-dimensional cytometry, and B-cell receptor sequencing have uncovered a dynamic continuum of B-cell differentiation programs that drive clinical heterogeneity across systemic autoimmune diseases. Plasmablasts, in particular, have gained recognition as highly responsive sensors of immune activation: they expand during flares, encode interferon-driven and extrafollicular responses, and correlate with disease severity. Autoantibody profiles, long viewed as static diagnostic signatures, are now understood as durable molecular footprints of distinct B-cell pathways. In this review, we propose an endotype-based framework integrating B-cell circuits with clinical phenotypes, illustrate therapeutic decision-making through mechanistic case vignettes, and outline future strategies combining immunomonitoring, multi-omics, and precision therapeutics. We further address translational challenges and discuss complementary approaches, including T-cell modulation, FcRn inhibition, and antigen-specific tolerization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
ORCID-Profile: Julie Sarrand, Muhammad Soyfoo
Zitieren
APA
Sarrand, J., & Soyfoo, M. (2026). B-Cells and Plasmablasts as Architects of Autoimmune Disease: From Molecular Footprints to Precision Therapeutics. Cells, 15(2), 119. https://doi.org/10.3390/cells15020119
Vancouver
Sarrand J, Soyfoo M. B-Cells and Plasmablasts as Architects of Autoimmune Disease: From Molecular Footprints to Precision Therapeutics. Cells. 2026;15(2):119. doi:10.3390/cells15020119
BibTeX
@article{Sarrand2026,
author = {Sarrand, Julie and Soyfoo, Muhammad},
title = {B-Cells and Plasmablasts as Architects of Autoimmune Disease: From Molecular Footprints to Precision Therapeutics},
journal = {Cells},
year = {2026},
volume = {15},
number = {2},
pages = {119},
doi = {10.3390/cells15020119}
}
EUVIMED